Q32 Bio Inc.
QTTB
$5.94
$0.132.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -54.83% | -68.56% | -75.22% | -27.46% | 4,437.58% |
| Gross Profit | 54.83% | 578.16% | 75.22% | 27.46% | -4,437.58% |
| SG&A Expenses | -11.76% | 14.12% | -9.98% | -11.05% | 2.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.85% | -45.90% | -59.73% | -48.82% | -17.62% |
| Operating Income | 36.85% | 415.84% | 59.73% | 48.82% | 17.62% |
| Income Before Tax | 31.02% | 507.47% | 58.01% | 44.11% | -1,172.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 31.02% | 506.86% | 58.01% | 44.11% | -1,172.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.02% | 506.86% | 58.01% | 44.11% | -1,172.01% |
| EBIT | 36.85% | 415.84% | 59.73% | 48.82% | 17.62% |
| EBITDA | 36.97% | 419.10% | 59.95% | 48.98% | 17.74% |
| EPS Basic | 40.31% | 494.47% | 58.57% | 45.18% | -187.47% |
| Normalized Basic EPS | 40.30% | 252.01% | 58.57% | 45.18% | -187.47% |
| EPS Diluted | 40.29% | 493.80% | 58.66% | 45.07% | 85.71% |
| Normalized Diluted EPS | 40.30% | 251.65% | 58.57% | 45.18% | -305.15% |
| Average Basic Shares Outstanding | 15.56% | 3.14% | 1.36% | 1.95% | 1,125.52% |
| Average Diluted Shares Outstanding | 15.56% | 3.38% | 1.36% | 1.95% | 422.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |